Key result
Combined PFA and LAAC proves safe and feasible with favorable early imaging outcomes.
Why the study?
Concomitant pulsed field ablation and left atrial appendage closure offers a single-procedure approach for AF management, but its workflow, safety, and feasibility in routine practice require assessment.
Is concomitant pulsed field ablation and left atrial appendage closure feasible and safe in patients with atrial fibrillation?
Observational (n=209)
No
Is concomitant pulsed field ablation and left atrial appendage closure feasible and safe in patients with atrial fibrillation?
Concomitant pulsed field ablation and left atrial appendage closure is a safe and procedurally efficient single-procedure approach for patients with atrial fibrillation, showing excellent early imaging outcomes.
Supports feasibility of combined pulsed field ablation and left atrial appendage closure; leaves open confirmation in multicenter randomized trials.
AIMS: Concomitant pulsed field ablation (PFA) for atrial fibrillation (AF) with left atrial appendage closure (LAAC) offers a single-procedure approach for arrhythmia control and thromboembolic risk reduction. This study assessed the workflow, safety, and feasibility of combined PFA and LAAC in routine practice. METHODS AND RESULTS: We prospectively analysed patients undergoing zero-fluoroscopy PFA, with low fluoroscopy for LAAC. Pre-procedural planning used CT imaging and AI-based models for device selection and landing-zone assessment. A single transseptal puncture facilitated intracardiac echocardiography, PFA catheter, and LAAC sheath. A total of 209 patients were included (56% male; mean age 76.5 ± 7.8 years), with 59.3% paroxysmal AF, 40.7% persistent AF, and 50% de novo AF. The mean CHA2DS2-VASc score was 4.5. Mean procedure and left atrial dwell times were 57.3 ± 17 and 45.1 ± 13.6 min, respectively; fluoroscopy averaged 3.4 ± 0.8 min for LAAC. A single LAAC device was used in 94% of cases, achieving adequate seal in all. No pericardial effusion, phrenic nerve injury, kidney, or oesophageal injury occurred; two patients had minor groin bleeding. All were discharged same day on oral anticoagulation for 90 days. Follow-up CT (80%) or TEE (20%) at 111.6 ± 16.5 days showed no leaks >2 mm, a 4.7% small-leak rate, and two device-related thrombi without stroke, managed with extended anticoagulation. CONCLUSION: Combined PFA and LAAC is feasible and safe with favourable early outcomes. Multi-centre studies are warranted to confirm findings and standardize this workflow for broader clinical adoption.
No takes yet. Share an insight, caveat, or question.
Doty et al. (2026) conducted an observational in Atrial fibrillation (n=209). Combined pulsed field ablation (PFA) and left atrial appendage closure (LAAC) was evaluated on Workflow, safety, and feasibility. Combined pulsed field ablation and left atrial appendage closure was feasible and safe, achieving adequate seal in all patients with no major procedural complications and a 4.7% small-leak rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: